Koyfin Home > Directory > Health Care > Acceleron Pharma > Total Assets

Acceleron Pharma Total Assets Chart (XLRN)

Acceleron Pharma annual/quarterly Total Assets from 2012 to 2020.
  • Acceleron Pharma Total Assets for the quarter ending June 06, 2020 was $479m a -8.39% decrease of -40m year over year
  • Acceleron Pharma Total Assets for the last 12 months ending June 06, 2020 was $479m a -8.39% decrease of -40m year over year
  • Acceleron Pharma Annual Total Assets for 2019 was $505m a 37.65% increase of 190m from 2018
  • Acceleron Pharma Annual Total Assets for 2018 was $315m a -23.62% decrease of -74m from 2017
  • Acceleron Pharma Annual Total Assets for 2017 was $389m a 36.37% increase of 142m from 2016
Other Balance Sheet Metrics:
  • Acceleron Pharma Other Liabilities for the quarter ending December 12, 2018 was $4m a 14.46% increase of 1m year over year
  • Acceleron Pharma Total Equity for the quarter ending September 09, 2018 was $319m a -14.45% decrease of -46m year over year
View Chart On Koyfin

Quarterly XLRN Total Assets Data

06/2020$479m
03/2020$464m
12/2019$505m
09/2019$520m
06/2019$551m
03/2019$560m
12/2018$315m
09/2018$338m
06/2018$352m
03/2018$370m

Annual XLRN Total Assets Data

2019$505m
2018$315m
2017$389m
2016$248m
2015$146m
2014$186m
2013$124m
2012$49m
2011$74m